City National Bank’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q3
$664K Buy
10,800
+24
+0.2% +$1.68K 0.01% 513
2015
Q2
$781K Sell
10,776
-1,121
-9% -$82.8K 0.01% 529
2015
Q1
$915K Buy
11,897
+795
+7% +$56.9K 0.01% 502
2014
Q4
$744K Sell
11,102
-24,221
-69% -$1.53M 0.01% 560
2014
Q3
$2.14M Sell
35,323
-208
-0.6% -$12.8K 0.02% 371
2014
Q2
$2.08M Buy
35,531
+15,801
+80% +$925K 0.02% 388
2014
Q1
$1.14M Buy
19,730
+1,831
+10% +$98.1K 0.02% 387
2013
Q4
$958K Sell
17,899
-4,408
-20% -$261K 0.01% 435
2013
Q3
$1.38M Sell
22,307
-416
-2% -$24.9K 0.02% 344
2013
Q2
$1.38M Buy
+22,723
New +$1.35M 0.03% 356

Other funds holding DGX

City National Bank's DGX Position: Q3 2015 in Review

City National Bank increased its Quest Diagnostics (DGX) stake by 0.22% in Q3 2015, buying an estimated $1.68K and bringing the position to 10,800 shares worth $664K. The position accounts for 0.01% of the portfolio, ranked #513.

City National Bank first reported a position in DGX in Q2 2013 and has held it in 10 quarters since. The position peaked at $2.14M in Q3 2014. 540 funds tracked by Wall St. Rank hold DGX as of Q3 2015.

  • City National Bank held 10,800 shares of Quest Diagnostics worth $664K as of Q3 2015.
  • City National Bank bought 24 Quest Diagnostics shares in Q3 2015, an estimated $1.68K.
  • Quest Diagnostics made up 0.01% of City National Bank's portfolio in Q3 2015, its #513 holding.
  • City National Bank first reported a position in Quest Diagnostics in Q2 2013 and has held it in 10 quarters since.
  • City National Bank's Quest Diagnostics position peaked at $2.14M in Q3 2014.
  • 540 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2015.

Based on City National Bank's 13F filing for Q3 2015, filed 29 Oct 2015.